www.fdanews.com/articles/201688-quibim-earns-fda-clearance-for-prostate-mri-solution
![ClearanceStamp_Gray.gif](https://www.fdanews.com/ext/resources/test/Device_Images6/ClearanceStamp_Gray.gif?t=1576043982&width=430)
Quibim Earns FDA Clearance for Prostate MRI Solution
March 5, 2021
Quibim has received FDA 510(k) clearance for qp-Prostate, an artificial intelligence-based magnetic resonance imaging (MRI) solution for analyzing the prostate.
The non-invasive solution assists in visualizing and quantifying the prostate to potentially help detect prostate cancer early on in patients.
The Valencia, Spain-based company said qp-Prostate is the only technology available that offers automatic regional organ segmentation that can help reduce interpretation time by identifying and segmenting each prostate region.